Randy Milby - May 20, 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (HILS)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Stock symbol
HILS
Transactions as of
May 20, 2022
Transactions value $
$918
Form type
4
Date filed
5/23/2022, 04:15 PM
Previous filing
May 19, 2022
Next filing
May 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Purchase $445 +500 +0.02% $0.89 2.94M May 20, 2022 Direct
transaction HILS Common Stock Purchase $473 +500 +0.02% $0.95 2.94M May 20, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.